Sentinel Diagnostics at MEDICA 2026: diagnostic solutions for every stage of the patient journey

Sentinel Diagnostics at MEDICA 2026: diagnostic solutions for every stage of the patient journey

From 16 to 19 November 2026, Sentinel Diagnostics will be exhibiting at MEDICA in Düsseldorf alongside PRIMA Lab and Eureka Lab Division. The Group looks forward to welcoming visitors to Hall 3 – Stand 3D16.

A 360° approach to diagnostics

The joint presence of the Group’s three companies reflects a shared vision of diagnostics: providing reliable, complementary tools that can address the different clinical and organizational needs arising at every stage of patient management.

From laboratory-based diagnostics to near-patient solutions and home tests designed for self-testing, the Group’s portfolio helps create diagnostic pathways that are more accessible, automated and focused on continuity of care.

The goal is to help ensure that diagnostic information is available at the most appropriate time and in the most appropriate setting, supporting informed clinical decisions and effective long-term monitoring.

Focus on gastroenterology and oncology

During MEDICA 2026, particular attention will be devoted to gastroenterology and oncology—two areas in which prevention, early identification, diagnostic investigation and follow-up play an essential role.

Visitors to the stand will have the opportunity to learn about the available solutions designed to support the diagnostic process throughout the different stages of the patient journey, from prevention and screening through diagnostic assessment, monitoring and follow-up. By combining the expertise of Sentinel Diagnostics, PRIMA Lab and Eureka Lab Division, the Group is able to offer a broad, coordinated portfolio designed to support the management of gastrointestinal and oncological conditions through a comprehensive approach.

Discover SENTiFIT® 300 Analyzer

During the event, we will introduce SENTiFIT® 300 Analyzer, a new fecal dedicated platform, developed to support laboratory needs in colorectal cancer screening programs and in the triage of patients with gastrointestinal symptoms.

Its patented automated fecal sample handling technology enables direct access to the specimen through a pierceable collection tube, reducing manual handling, and helping to make the analytical process safer and more hygienic.

The importance of home test

A further focus will be placed on PRIMA home tests: simple, practical solutions that encourage greater awareness of personal health.

Self-tests allow individuals to perform preventive checks independently and represent a first step toward greater awareness of their health. For any further evaluation or diagnostic confirmation, consultation with a physician is always recommended.

Meet us in Düsseldorf

MEDICA 2026 will be an opportunity to meet partners, customers and industry professionals, share expertise, and explore the Group’s diagnostic solutions supporting every stage of the patient journey.

We look forward to seeing you in Düsseldorf from 16th to 19th November 2026.

Hall 3 – Stand 3D16

Book an appointment with our sales team at sentinel@sentinel.it